Chitosan and nanochitosan haemostatic agents attenuate haemorrhagic coagulopathy and fibrinolysis: a rabbit study
Abstract
Background
Uncontrolled haemorrhage is the leading cause of potentially survivable death in combat casualties.
Aim
To compare the effects of a chitosan-based and a nanochitosan-based haemostatic agent with a reference agent on coagulation, fibrinolysis, platelets and angiogenic growth factors in an experimental haemorrhage model.
Methods
Thirty adult rabbits (2.1–2.3 kg) were randomly allocated to five groups (n = 6): intact, untreated haemorrhage (control), reference agent, chitosan and nanochitosan. Blood loss, bleeding time, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), international normalised ratio (INR), fibrinogen, D-dimer, platelet count, vascular endothelial growth factor (VEGF) and transforming growth factor-β (TGF-β) were measured 1, 3, 12, 24 and 72 h after injury.
Results
In untreated animals, blood loss was 8.27–8.50 mL and bleeding time 19.8–23.6 min. Haemorrhage prolonged PT (12.83 to 16.55 s) and APTT (36.83 to 64.5 s), increased D-dimer more than fivefold (0.25 to 1.33 µg/mL) and reduced platelets (333.3 to 237.2 × 103/µL) by 72 h. All agents attenuated these changes, most markedly nanochitosan: PT was 9.4% and 11.0% shorter than in controls at 1 and 72 h, APTT 12.2% and 12.7% shorter, D-dimer 2.2-fold lower (0.47 and 0.60 vs. 1.03 and 1.33 µg/mL) and platelets higher (278.5 and 280.0 vs. 249.0 and 237.2 × 103/µL). Haemorrhage increased VEGF (97.5 to 189.7 ng/mL) and TGF-β (72.7 to 267.5 pg/mL); the rise was smallest with nanochitosan (152.8 ng/mL and 238.5 pg/mL at 72 h).
Conclusion
In this rabbit model, nanochitosan attenuated haemorrhage-associated coagulopathy, hyperfibrinolysis and thrombocytopenia more effectively than conventional chitosan or the reference agent. Confirmation of local haemostatic efficacy and thrombotic safety in standardised large-animal models is required before clinical use.
Keywords
Blood Coagulation; Chitosan; Hemorrhage; Hemostatics; Nanoparticles; Wounds and Injuries
Full article
How to cite
Tukhtapulatov A. T., Pulatova Z. A., Milusheva R. Y., Raxmanova V. N., Axmedova D. B., Mirdjalilov F. X., Xasanov Z. R. (2026). Chitosan and nanochitosan haemostatic agents attenuate haemorrhagic coagulopathy and fibrinolysis: a rabbit study. Journal of Taibah University Medical Sciences, 21(5), 1260–1273. DOI: 10.1016/j.jtumed.2026.10.19.
Recommended articles
Clinical and Functional Phenotypes of Hypertension and Early Cardiovascular Remodeling in Young Men Serving in the Security and Defense Agencies of the Republic of Uzbekistan
Journal of Taibah University Medical Sciences · 05-09-2026
Systemic and local immune responses in children with apical periodontitis and their modification by adjunctive immunotropic treatment
Journal of Taibah University Medical Sciences · 14-09-2026